Search results for 'Cadila Healthcare'

Who donated how much to BJP, Congress

Who donated how much to BJP, Congress

Rediff.com18 Jan 2019

Who donated how much to BJP, Congress

Can these stocks shine amid market gloom?

Can these stocks shine amid market gloom?

Rediff.com8 Mar 2018

Investors turn their attention to export-driven sectors.

Ask Ajit: Stocks to BUY, HOLD or SELL

Ask Ajit: Stocks to BUY, HOLD or SELL

Rediff.com18 Aug 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

36 drugs to be cheaper as govt caps prices

36 drugs to be cheaper as govt caps prices

Rediff.com19 Sep 2014

India has capped the prices of 36 drugs, including those used to treat infections and diabetes, in its latest move to make essential medicines more affordable, a senior official of the country's drug pricing authority told Reuters on Friday.

Zydus infringed Takeda's patent, rules US court

Zydus infringed Takeda's patent, rules US court

Rediff.com20 Jun 2013

Takeda had filed a case of patent infringement in response to Zydus' abbreviated new drug application.

Ask Ajit: Stocks to buy, hold, sell

Ask Ajit: Stocks to buy, hold, sell

Rediff.com13 Jan 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

First-time investor: 'I can afford only low-price stocks'

First-time investor: 'I can afford only low-price stocks'

Rediff.com12 Jan 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Why a weak rupee is bad news for India

Why a weak rupee is bad news for India

Rediff.com16 Aug 2018

With India's imports exceeding exports, weak rupee does more harm than good. Analysts, however, say that rupee depriciation is positive for export-oriented sectors such as IT services, pharmaceuticals, textiles and automobiles

Myanmar allows traffic rights to Indian airlines

Myanmar allows traffic rights to Indian airlines

Rediff.com10 Jun 2013

At present, there is no direct air connectivity between India and Myanmar.

Scientists urge caution over launch of Covid vaccine by Aug 15

Scientists urge caution over launch of Covid vaccine by Aug 15

Rediff.com4 Jul 2020

'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'

24 SEZ developers seek more time for projects

24 SEZ developers seek more time for projects

Rediff.com16 Jan 2014

As many as 24 special economic zone (SEZ) developers including Dr Reddy's Lab and Tata Consultancy Services have sought more time from the government to execute their projects.

Sun Pharma's Dilip Shanghvi takes 99% pay cut

Sun Pharma's Dilip Shanghvi takes 99% pay cut

Rediff.com2 Aug 2019

As on July 31, the valuation of his shareholding in the company stood at Rs 9,830 crore.

'We are a consumption-based economy, demand will not go away easily'

'We are a consumption-based economy, demand will not go away easily'

Rediff.com4 Dec 2017

For India Inc, latest GDP figures signal a turnaround.

14 Indian families in Asia's richest list; Ambanis on 3rd

14 Indian families in Asia's richest list; Ambanis on 3rd

Rediff.com8 Oct 2015

As many as 14 Indian families have made it to the inaugural list of Forbes' 50 richest families in Asia.

'It was very hard to build an R&D set-up in India'

'It was very hard to build an R&D set-up in India'

Rediff.com25 Jul 2017

Sohini Das chats with MD of Zydus Cadila Healthcare Pankaj R Patel & his son Sharvil Patel.

The REAL story behind zero #MeToo cases

The REAL story behind zero #MeToo cases

Rediff.com16 Nov 2018

Audit firms such as KPMG believe zero complaints may be an indicator of the lack of requisite mechanism to allow for such reporting

Stocks to create long-term wealth

Stocks to create long-term wealth

Rediff.com25 Sep 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Stocks you must buy, hold or exit

Stocks you must buy, hold or exit

Rediff.com25 Aug 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries:

IIM-A director Ashish Nanda steps down citing personal reasons

IIM-A director Ashish Nanda steps down citing personal reasons

Rediff.com28 Apr 2017

An alumnus of IIM-A from the 1983 batch, Nanda was a Robert Braucher Professor of Practice at Harvard Law School and later a Harvard Business School faculty member, before he took charge on September 2, 2013.

Making losses in stocks? Here's help

Making losses in stocks? Here's help

Rediff.com21 Sep 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries

After ban on drug facilities, US regulator comes calling

After ban on drug facilities, US regulator comes calling

Rediff.com10 Feb 2014

Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.

India, China sign business deals worth $3.4 billion

India, China sign business deals worth $3.4 billion

Rediff.com18 Sep 2014

IndiGo Airlines signs $2.6-billion leasing and financing MoU with Industrial and Commercial Bank of China.

Indian drug makers face heat of US regulator's crackdown

Indian drug makers face heat of US regulator's crackdown

Rediff.com23 Jun 2013

Data also show that several other leading domestic pharma companies have recalled their products from the US

First-time women directors deepen talent pool

First-time women directors deepen talent pool

Rediff.com13 Apr 2015

BSE-200 companies's list shows that 96 companies had woman directors.

Indian drug cos to benefit as US expedites generic clearances

Indian drug cos to benefit as US expedites generic clearances

Rediff.com12 May 2014

Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.

Anil Agarwal, Adanis, Ambanis lose the most in Modi regime

Anil Agarwal, Adanis, Ambanis lose the most in Modi regime

Rediff.com9 Sep 2015

The calculation excludes cross-holding of listed group cos in each other.

3 Indian pharma firms named in US Congress price probe

3 Indian pharma firms named in US Congress price probe

Rediff.com9 Oct 2014

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months

Big corporate donors to the BJP, Congress in FY14

Big corporate donors to the BJP, Congress in FY14

Rediff.com16 Feb 2015

Biggest contribution came from Bharti group-led Satya Electoral Trust.

Modi was unusually soft and humble

Modi was unusually soft and humble

Rediff.com27 May 2014

Glimpses of the change Narendra Modi promised million of voters were visible at Rashtrapati Bhavan. Modi has now no excuse, but to perform and change India for the better. Sheela Bhatt/Rediff.com reports from the presidential palace. A feature on the swearing-in ceremony like none other.

Drugmakers draw more FDA scrutiny as US imports rise

Drugmakers draw more FDA scrutiny as US imports rise

Rediff.com13 Sep 2013

And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.

Dholera: Modi's pet project back on the fast track

Dholera: Modi's pet project back on the fast track

Rediff.com25 Oct 2014

Armed with green nod and fund infusion, Gujarat govt getting ready to issue tenders to build infrastructure at the mega investment region

« Prev  |